Literature DB >> 21177979

Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Elisa Ghelfi1, Cagatay Karaaslan, Sara Berkelhamer, Serra Akar, Harry Kozakewich, Sule Cataltepe.   

Abstract

Inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia (BPD). Fatty acid-binding proteins (FABPs) 4 and 5 regulate the inflammatory activity of macrophages. Whether FABPs 4 and 5 could play a role in the pathogenesis of BPD via the promotion of macrophage inflammatory activity is unknown. This study sought to examine whether the expression levels of FABP4 and FABP5 were altered in bronchoalveolar lavage fluid and lung tissue in a baboon model of BPD. This study also sought to characterize the cell types that express these proteins. Real-time PCR, immunoblotting, immunohistochemistry, and double immunofluorescence were used to examine the expression of FABPs in samples of BPD. Morphometric analysis was used to quantify FABP4-positive peribronchial blood vessels in lung sections. FABP4 was primarily expressed in macrophages in samples of BPD. In addition, FABP4 was expressed in the endothelial cells of blood vessels in peribronchial areas and the vasa vasorum, but not in the alveolar vasculature in samples of BPD. FABP4 concentrations were significantly increased in lungs and bronchoalveolar lavage fluid samples with BPD. An increased density of FABP4-positive peribronchial blood vessels was evident in both baboon and human BPD sections. FABP5 was expressed in several cell types, including alveolar epithelial cells and macrophages. FABP5 concentrations did not show any significant alterations in BPD. In conclusion, FABP4 but not FABP5 levels are increased in BPD. FABP4 is differentially expressed in endothelial cells of the bronchial microvasculature, which demonstrates a previously unrecognized expansion in BPD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177979      PMCID: PMC3175587          DOI: 10.1165/rcmb.2010-0376OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

1.  Localization of epidermal-type fatty acid binding protein in alveolar macrophages and some alveolar type II epithelial cells in mouse lung.

Authors:  Y Owada; S A Abdelwahab; R Suzuki; H Iwasa; H Sakagami; F Spener; H Kondo
Journal:  Histochem J       Date:  2001-08

2.  Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

Authors:  B Jónsson; K Tullus; A Brauner; Y Lu; G Noack
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

3.  Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons.

Authors:  William M Maniscalco; Richard H Watkins; Gloria S Pryhuber; Abhay Bhatt; Colleen Shea; Heidie Huyck
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

4.  Neonatal chronic lung disease in extremely immature baboons.

Authors:  J J Coalson; V T Winter; T Siler-Khodr; B A Yoder
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

Review 5.  Bronchial vascular congestion and angiogenesis.

Authors:  N B Charan; E M Baile; P D Paré
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

6.  Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes.

Authors:  Elizabeth J Short; Nancy K Klein; Barbara A Lewis; Sarah Fulton; Sheri Eisengart; Carolyn Kercsmar; Jill Baley; Lynn T Singer
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

7.  Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity.

Authors:  S Kotecha; L Wilson; A Wangoo; M Silverman; R J Shaw
Journal:  Pediatr Res       Date:  1996-08       Impact factor: 3.756

Review 8.  Fatty acid-binding proteins--insights from genetic manipulations.

Authors:  Norbert H Haunerland; Friedrich Spener
Journal:  Prog Lipid Res       Date:  2004-07       Impact factor: 16.195

9.  Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism.

Authors:  F Guthmann; C Hohoff; H Fechner; P Humbert; T Börchers; F Spener; B Rüstow
Journal:  Eur J Biochem       Date:  1998-04-15

10.  Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: contribution of caveolin-1 and PPARgamma.

Authors:  Florian Guthmann; Christian Schachtrup; Angelika Tölle; Heide Wissel; Bert Binas; Hisatake Kondo; Yuji Owada; Friedrich Spener; Bernd Rüstow
Journal:  Biochim Biophys Acta       Date:  2004-03-22
View more
  25 in total

1.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

2.  Fatty acid binding proteins as biomarkers of disease severity and response to treatment in severe pneumonia required admission to intensive care unit.

Authors:  Han-Chen Tsai; Shi-Chuan Chang
Journal:  Ann Transl Med       Date:  2016-10

3.  Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia.

Authors:  Cagatay Karaaslan; Hiroshi Hirakawa; Ryuji Yasumatsu; Ling-Yi L Chang; Richard A Pierce; James D Crapo; Sule Cataltepe
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

4.  Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses.

Authors:  Chen-Wei Yu; Xiaoliang Liang; Samantha Lipsky; Cagatay Karaaslan; Harry Kozakewich; Gokhan S Hotamisligil; Joyce Bischoff; Sule Cataltepe
Journal:  Angiogenesis       Date:  2015-12-01       Impact factor: 9.596

Review 5.  Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis.

Authors:  Haifeng Zhao; Phyllis A Dennery; Hongwei Yao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

6.  Mouse lung development and NOX1 induction during hyperoxia are developmentally regulated and mitochondrial ROS dependent.

Authors:  Ankur Datta; Gina A Kim; Joann M Taylor; Sylvia F Gugino; Kathryn N Farrow; Paul T Schumacker; Sara K Berkelhamer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-19       Impact factor: 5.464

7.  Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment.

Authors:  Raquel Català; Anna Cabré; Salvador Hernández-Flix; Raimón Ferré; Sandra Sangenís; Núria Plana; Anna Texidó; Lluís Masana
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

8.  Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.

Authors:  Elisa Ghelfi; Chen-Wei Yu; Harun Elmasri; Matthew Terwelp; Chun G Lee; Vineet Bhandari; Suzy A Comhair; Serpil C Erzurum; Gökhan S Hotamisligil; Jack A Elias; Sule Cataltepe
Journal:  Am J Pathol       Date:  2013-02-04       Impact factor: 4.307

9.  THE ROLE OF MITOCHONDRIAL FATTY ACID USE IN NEONATAL LUNG INJURY AND REPAIR.

Authors:  Phyllis A Dennery; Jennifer Carr; Abigail Peterson; Hongwei Yao
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

10.  Impaired Autophagic Activity Contributes to the Pathogenesis of Bronchopulmonary Dysplasia. Evidence from Murine and Baboon Models.

Authors:  Liang Zhang; Sourabh Soni; Elvin Hekimoglu; Sara Berkelhamer; Sule Çataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.